BRIJ Medical logo representing the US medical technology company developing surgical wound closure and incision management devices.
US medical technology company BRIJ Medical has secured $5 million in financing led by its Board of Directors, with strong participation from existing investors. The capital will support commercial expansion and the planned launch of BRIJ-Ag.

BRIJ Medical, a US-based medical technology company specialising in surgical incision management, has closed a $5 million financing round led by its Board of Directors, with most of the participation coming from existing investors.

Announced on November 3, 2026, the financing was increased from an initial $3 million target to $5 million following additional investor demand.

An October 23, 2026, filing with the US Securities and Exchange Commission disclosed a $5 million securities offering that included debt and convertible promissory notes convertible into preferred stock.

BRIJ Medical was founded by plastic surgeon Dr. Felmont (Monte) Eaves III, who serves as its Chief Medical Officer. The company is led by CEO Tim Gleeson and develops medical devices designed to support surgical wound closure, protect incisions and reduce tension on healing tissue.

Its product portfolio includes Brijjit, a tissue-bridge device designed to offload tension from surgical incisions, and BRIJ-SEAL, an advanced wound closure and protection device that was commercially launched in July 2026. BRIJ-SEAL is designed to provide a bacterial barrier over surgical incisions for up to 14 days.

The company’s products are used across orthopedic, plastic and spine surgical procedures, with a commercial presence in the United States and Canada.

BRIJ Medical plans to use the new financing primarily to expand its commercial operations, increase surgeon access to BRIJ-SEAL and Brijjit, and support upcoming product introductions.

The company is also preparing to launch BRIJ-Ag, a silver-based antimicrobial wound dressing, during the fourth quarter of 2026. The planned introduction will expand its incision-management portfolio alongside its existing wound closure and tension-offloading devices.

Get the latest startup funding news in your inbox.

We don’t spam! Read our privacy policy for more info.

Share